Crystal's MCW Coder Hubπ§¬ICD-10 CM H30.101 β Unspecified Disseminated Chorioretinal Inflammation, Right Eye
Code Classification
ICD-10-CM Diagnosis Code β This is a diagnosis code. Fields for wRVU, assistant payable, and global period are not applicable. For associated inpatient procedure coding, see the ICD-10-PCS Crosswalk section below.
π Code Description
H30.101 classifies unspecified disseminated chorioretinal inflammation of the right eye β a widespread or multifocal inflammatory process involving the choroid (the richly vascularized middle coat of the eye) and the retina, occurring in the right eye, without further specification of anatomic distribution within the fundus or of an identifiable underlying etiology at the time of coding.1
The term disseminated distinguishes this condition from focal chorioretinal inflammation (H30.0x subcategory), which involves a single, discrete inflammatory lesion. Disseminated implies multiple scattered or coalescent foci throughout the posterior segment. The qualifier βunspecifiedβ within H30.10x reflects that, while the inflammation is documented as disseminated, the treating physician has not further characterized its precise anatomic distribution β that is, it has not been specified as posterior pole, peripheral, or generalized.
The inflammation may involve the choroidal stroma, choriocapillaris, and/or the retinal layers, with the terms chorioretinitis and retinochoroiditis used clinically to reflect direction of primary involvement; both map to H30.1x in ICD-10-CM.1
π³ Code Tree / Hierarchy
H30 Chorioretinal Inflammation
β
βββ H30.0 Focal chorioretinal inflammation
β βββ H30.00x Unspecified focal chorioretinal inflammation
β β βββ H30.001 Right eye
β β βββ H30.002 Left eye
β β βββ H30.003 Bilateral
β β βββ H30.009 Unspecified eye
β βββ H30.01x Focal, juxtapapillary
β βββ H30.02x Focal, posterior pole
β βββ H30.03x Focal, peripheral
β βββ H30.04x Focal, macular or paramacular
β
βββ H30.1 Disseminated chorioretinal inflammation β PARENT CATEGORY
β βββ H30.10x Unspecified disseminated chorioretinal inflammation
β β βββ H30.101 Right eye β THIS CODE
β β βββ H30.102 Left eye
β β βββ H30.103 Bilateral
β β βββ H30.109 Unspecified eye
β βββ H30.11x Disseminated chorioretinal inflammation, posterior pole
β β βββ H30.111 Right eye
β β βββ H30.112 Left eye
β β βββ H30.113 Bilateral
β β βββ H30.119 Unspecified eye
β βββ H30.12x Peripheral disseminated chorioretinal inflammation
β β βββ H30.121 Right eye
β β βββ H30.122 Left eye
β β βββ H30.123 Bilateral
β β βββ H30.129 Unspecified eye
β βββ H30.13x Generalized disseminated chorioretinal inflammation
β βββ H30.131 Right eye
β βββ H30.132 Left eye
β βββ H30.133 Bilateral
β βββ H30.139 Unspecified eye
β
βββ H30.2 Posterior cyclitis (pars planitis)
β βββ H30.20 Unspecified eye
β βββ H30.21 Right eye
β βββ H30.22 Left eye
β βββ H30.23 Bilateral
β
βββ H30.8 Other chorioretinal inflammations
βββ H30.9 Unspecified chorioretinal inflammation
Code to Highest Specificity
If the physician documents that the disseminated inflammation is confined to the posterior pole, assign H30.111 (right eye) in preference to H30.101. If documented as peripheral, use H30.121; if generalized, use H30.131. H30.101 should only be assigned when the distribution is genuinely unspecified or undocumented. A CDI query is appropriate if the distribution appears clinically determinable from the record.
Laterality β Do Not Default to " Unspecified Eye"
Always assign the laterality-specific code when documented. Reserve H30.109 (unspecified eye) only when laterality is truly indeterminate after query. Failure to assign laterality risks DRG accuracy and payer compliance.
β Includes
The following clinical terms are classified to H30.101 and its parent subcategory H30.10x (Unspecified disseminated chorioretinal inflammation):1
- Disseminated chorioretinitis, NOS β right eye
- Disseminated choroiditis, NOS β right eye
- Disseminated retinitis, NOS β right eye
- Disseminated retinochoroiditis, NOS β right eye
These terms reflect widespread, multifocal inflammation of the posterior uvea and/or retina without further specification of anatomic distribution or documented etiology. The terms chorioretinitis (choroid β retina involvement) and retinochoroiditis (retina β choroid involvement) are used interchangeably in clinical documentation and map identically to this code.1
β Excludes
Excludes 1 β Cannot Be Coded Simultaneously with H30.1011
| Code | Description | Note |
|---|---|---|
| H35.02- | Exudative retinopathy (Coats disease) | Mutually exclusive β if exudative retinopathy is the diagnosis, assign only H35.02- with appropriate laterality |
Excludes 1 Violation Risk
H35.02- (exudative retinopathy / Coats disease) carries an Excludes 1 instruction at the H30.1 subcategory level. These conditions are mutually exclusive and cannot be assigned simultaneously. Coats disease presents with retinal telangiectasia and exudation that can mimic inflammatory chorioretinal disease β careful clinical distinction is required. If the diagnosis is Coats disease, assign H35.021 (right eye), not H30.101.
Excludes 2 β May Be Coded in Addition if Separately Present1
| Code | Description | Note |
|---|---|---|
| H44.1- | Sympathetic uveitis | Excludes 2 at the H30 category level β may be coded additionally if separately documented and clinically distinct |
Excludes 2 β Not Mutually Exclusive
H44.1- (sympathetic uveitis) is an Excludes 2 entry at the H30 category level. Both codes may be assigned if sympathetic uveitis is separately and distinctly documented alongside chorioretinal inflammation. Do not routinely add H44.1- without explicit physician documentation.
π Clinical Overview
Pathophysiology
Disseminated chorioretinal inflammation represents a diffuse or multifocal inflammatory process affecting the choroid and/or retina. The choroid is the vascular layer lying between the sclera and the retinal pigment epithelium (RPE), supplying the outer retinal layers with oxygen and nutrients via the choriocapillaris. Inflammation in this layer disrupts the outer blood-retinal barrier, leading to photoreceptor damage, RPE dysfunction, and potential vision loss.2
Unlike focal chorioretinitis, the disseminated form features multiple scattered or confluent lesions throughout the fundus, often bilaterally (though H30.101 specifies right eye involvement). The widespread nature of the inflammatory response suggests either hematogenous seeding (as in infectious etiologies), an immune-mediated mechanism with diffuse choroidal involvement, or both.
Etiology
Disseminated chorioretinal inflammation may be infectious, autoimmune/immune-mediated, or idiopathic. Identification of the underlying cause governs both treatment and coding sequencing.2
Infectious causes (code the organism when identified):
| Organism | ICD-10-CM Code | Sequencing Note |
|---|---|---|
| Toxoplasma gondii | B58.01 | Primary code; H30.101 may be added for disseminated pattern specificity |
| Secondary syphilis (ocular) | A51.43 | Code etiology; H30.101 adds pattern detail |
| Late syphilitic chorioretinitis | A52.71 | Per tabular guidance |
| Tuberculous chorioretinitis | A18.53 | Code etiology first |
| Cytomegalovirus (CMV) retinitis | B25.8 | In immunocompromised; B20 sequences first in HIV |
| Candidal endophthalmitis / chorioretinitis | B37.89 | Code candidiasis of other site |
Non-infectious / immune-mediated (no organism code; H30.101 is primary):
- Birdshot chorioretinopathy (HLA-A29 associated)
- sarcoidosis with ocular involvement (code D86.8x additionally)
- Vogt-Koyanagi-Harada (VKH) syndrome
- Systemic lupus erythematosus with ocular manifestation
- Multiple evanescent white dot syndrome (MEWDS)
- Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)
Idiopathic: When no etiology is identified after workup, H30.101 stands alone as the principal or secondary diagnosis.
Sequencing Principle
When a causative organism or systemic condition is identified and drives the admission, code the underlying etiology first, followed by H30.101 as a manifestation, per ICD-10-CM Official Coding Guidelines Chapter 1 (infectious diseases) and the tabular βcode firstβ conventions. If etiology is unknown, H30.101 sequences as the principal diagnosis without an additional organism code.
Clinical Presentation
Patients with disseminated chorioretinal inflammation typically present with one or more of the following:2
- Blurred vision or progressive visual loss in the affected eye, ranging from mild to severe
- Floaters β vitreous cells or debris creating scotomas and floaters in the visual field
- Photophobia and photopsia (flashes of light)
- Scotomas β visual field deficits corresponding to the anatomic location of lesions
- Periorbital pain or ocular discomfort, particularly when anterior uveitis coexists
- Fundoscopic findings on examination:
- Multiple white, yellow-white, or gray fluffy lesions scattered across the retina and/or choroid
- Associated vitritis (vitreous inflammatory cells β βheadlights in fogβ appearance)
- Possible retinal vasculitis, disc edema, or cystoid macular edema (CME) in severe cases
- Subretinal fluid or serous retinal detachment in advanced cases
Documentation Requirements
For accurate, defensible assignment of H30.101, physician documentation should include:
- Laterality β explicitly right eye, left eye, or bilateral
- Pattern β disseminated (multifocal, scattered) vs. focal (single lesion); this is the critical distinction between H30.0x and H30.1x
- Anatomic distribution β posterior pole, peripheral, or generalized (enables sub-subcategory specificity)
- Etiology or suspected cause β if identified, drives additional code assignment and sequencing
- Acuity/severity β relevant to CC/MCC capture and DRG assignment
- Active vs. inactive/scarring β impacts treatment decisions; may affect chronicity coding
CDI Query Opportunity
If the record documents βchorioretinitisβ without specifying focal vs. disseminated, or documents an infectious organism without an explicit causal link to the ocular finding, a clinical documentation improvement (CDI) query is warranted. Clarifying the pattern (focal vs. disseminated) and distribution (posterior pole vs. peripheral vs. generalized) allows assignment of a more specific subcategory code and may support CC/MCC capture that improves DRG reimbursement accuracy.
π° HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | β Not Mapped |
| HCC Category | N/A |
| RAF Coefficient | 0.000 |
| RxHCC Assignment | Not Mapped |
H30.101 does not map to a Hierarchical Condition Category (HCC) under CMS-HCC v28 and does not contribute to a patientβs Risk Adjustment Factor (RAF) score for Medicare Advantage payment purposes.3
Monitor for Vision-Threatening Sequelae
While H30.101 itself carries no HCC weight, documented sequelae resulting from disseminated chorioretinal inflammation may carry risk adjustment significance. Coders and CDI specialists should review for:
- Vision impairment or legal blindness β review H54.xx codes for applicable HCC mapping in the version in effect
- Any documented retinal detachment arising from inflammatory disease β review H33.0xx codes
- Systemic comorbidities driving or complicating the ocular disease (diabetes, HIV, autoimmune conditions) β these frequently carry HCC weight in their own right
Do not leave risk-adjustable comorbidities undercoded. All conditions meeting UHDDS criteria for βother diagnosesβ should be reported.
π₯ MS-DRG Assignment
MDC 02 β Diseases and Disorders of the Eye
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 124 | Other Disorders of the Eye with MCC | ~0.95-1.15 |
| DRG 125 | Other Disorders of the Eye with CC | ~0.70-0.90 |
| DRG 126 | Other Disorders of the Eye without CC/MCC | ~0.50-0.70 |
*Relative weights are approximate. Verify against the applicable IPPS FY2025 Final Rule tables for the fiscal year being coded.4
DRG Logic and Principal Diagnosis Sequencing
When H30.101 is assigned as the principal diagnosis, the encounter groups to MDC 02. Final DRG is then determined by the presence or absence of coded CCs and MCCs.
MCC examples relevant to an ophthalmology inpatient stay:
- Sepsis or septic shock
- Respiratory failure
- Acute kidney injury (AKI)
- HIV disease (B20) β note: see sequencing caveat below
- Acute MI, stroke, or other major organ failure
CC examples:
- Diabetes mellitus with complications
- Moderate-to-severe vision impairment
- Systemic infectious or inflammatory comorbidities
- Hypertension with target organ disease
HIV and Systemic Etiology β Principal Diagnosis May Shift MDC
If the patient is admitted with HIV disease (B20) and the chorioretinal inflammation is an HIV-related manifestation (e.g., CMV retinitis in an AIDS patient), B20 sequences as the principal diagnosis per ICD-10-CM Official Guidelines Chapter 1, Section C.1. In this scenario, the encounter groups to MDC 25 (HIV/AIDS), not MDC 02, and H30.101 is an additional diagnosis.
Similarly, if admission is driven by disseminated toxoplasmosis (B58.01) rather than the isolated ocular finding, sequence B58.01 as principal and H30.101 as additional. This shifts the DRG grouper accordingly β always evaluate the reason for the admission first.
π Related ICD-10-CM Codes
Laterality Variants of This Code
| Code | Description |
|---|---|
| H30.101 | Unspecified disseminated chorioretinal inflammation, right eye β This Code |
| H30.102 | Unspecified disseminated chorioretinal inflammation, left eye |
| H30.103 | Unspecified disseminated chorioretinal inflammation, bilateral |
| H30.109 | Unspecified disseminated chorioretinal inflammation, unspecified eye |
More Specific Disseminated Subcategories (Right Eye)
| Code | Description |
|---|---|
| H30.111 | Disseminated chorioretinal inflammation, posterior pole, right eye |
| H30.121 | Peripheral disseminated chorioretinal inflammation, right eye |
| H30.131 | Generalized disseminated chorioretinal inflammation, right eye |
Upgrade Specificity When Possible
If fundoscopic documentation supports posterior pole, peripheral, or generalized distribution, assign the more specific code rather than H30.101. βUnspecifiedβ distribution codes should be a last resort, not a default.
Focal Variants (H30.0x) β Right Eye
| Code | Description |
|---|---|
| H30.001 | Unspecified focal chorioretinal inflammation, right eye |
| H30.011 | Focal, juxtapapillary (Jensenβs chorioretinitis), right eye |
| H30.021 | Focal chorioretinal inflammation, posterior pole, right eye |
| H30.031 | Focal chorioretinal inflammation, peripheral, right eye |
| H30.041 | Focal chorioretinal inflammation, macular or paramacular, right eye |
Infectious Etiology Codes (Assign in Addition When Documented)
| Code | Description |
|---|---|
| B58.01 | Toxoplasma chorioretinitis |
| A51.43 | Secondary syphilitic oculopathy |
| A52.71 | Late syphilitic oculopathy (chorioretinitis) |
| A18.53 | Tuberculous chorioretinitis |
| B25.8 | Other cytomegaloviral diseases (CMV retinitis) |
| B20 | HIV disease (sequences as principal in HIV-related admissions) |
Associated and Differential Diagnosis Codes
| Code | Description | Coding Relevance |
|---|---|---|
| H30.21 | Posterior cyclitis (pars planitis), right eye | Distinct entity; inflammation is at the pars plana β not disseminated choroid/retina |
| H44.111 | Sympathetic uveitis, right eye | Excludes 2 at H30 level β may code additionally if distinctly documented |
| H35.021 | Exudative retinopathy (Coats disease), right eye | Excludes 1 β cannot code with H30.101; mutually exclusive |
| H33.001 | Retinal detachment with retinal break, right eye | Assign additionally if retinal detachment is a documented complication |
| H59.811 | Chorioretinal scars after surgery for detachment, right eye | Relevant post-procedural context |
π οΈ Commonly Associated CPT Codes (Ophthalmology)
Outpatient and Physician Setting Context
The CPT codes below are associated with the diagnostic workup and ongoing management of disseminated chorioretinal inflammation in outpatient and physician fee schedule settings. In the inpatient setting, ICD-10-PCS procedure codes govern procedural reporting. These CPT codes are presented for cross-reference and outpatient facility or professional claim context.
| CPT Code | Description | Clinical Application |
|---|---|---|
| 92004 | Ophthalmological exam, comprehensive, new patient | Initial workup, new presentation of chorioretinal inflammation |
| 92014 | Ophthalmological exam, comprehensive, established patient | Follow-up visits for known disseminated chorioretinitis |
| 92250 | Fundus photography with interpretation and report | Documents baseline lesion morphology, size, number; tracks progression |
| 92235 | Fluorescein angiography with interpretation and report | Evaluates vascular leakage, hyperfluorescence, late staining patterns at active lesions |
| 92240 | Indocyanine-green (ICG) angiography with interpretation and report | Superior for assessing choroidal involvement; useful in birdshot, VKH, and other choroidopathies |
| 92134 | Scanning computerized ophthalmic diagnostic imaging, posterior segment (OCT) | Retinal thickness mapping, subretinal fluid identification, CME detection |
| 92132 | Scanning computerized ophthalmic diagnostic imaging, anterior segment | If concurrent anterior uveitis or anterior segment pathology is also being evaluated |
| 67028 | Intravitreal injection of a pharmacologic agent | Intravitreal corticosteroid (e.g., triamcinolone) or antifungal therapy |
NCCI Bundling Considerations (Outpatient / Physician Setting)
NCCI PTP Edits β Verify Before Billing
- 92250 (fundus photography) and 92235 (fluorescein angiography) billed on the same date of service are subject to NCCI Procedure-to-Procedure (PTP) edit review. Confirm current edit status in the applicable NCCI table before billing both on the same DOS.
- 67028 (intravitreal injection) performed on the same date as an E/M service: Modifier -25 (significant, separately identifiable E/M) must be appended to the E/M code when both a significant E/M and the intravitreal injection are performed on the same date, and the E/M is separately documentable and medically necessary beyond the procedure itself. Without modifier -25, the E/M may be denied as bundled.
- 92235 and 92240 billed together: review current NCCI edits; ICG and fluorescein angiography may require separate medical necessity documentation if billed on the same encounter.
π¬ ICD-10-PCS Crosswalk (Inpatient Procedures)
When H30.101 is an inpatient diagnosis and a procedure is performed, the following ICD-10-PCS sections and root operations are relevant for code building. Full PCS codes require completion of all seven characters β consult the PCS tables for the applicable fiscal year.5
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| 3 (Administration) | E (Physiological Systems & Anatomical Regions) | 0 (Introduction) | Intravitreal injection of pharmacologic agent (corticosteroid, antiviral, antifungal) into the eye β Body Part C (Eye), Approach 3 (Percutaneous) |
| 0 (Medical & Surgical) | 8 (Eye) | 9 (Drainage) | Diagnostic vitreous aspiration or tap for culture/PCR β Body Part: Vitreous (Right = 5), Approach 3 (Percutaneous), Qualifier X (Diagnostic) |
| 0 (Medical & Surgical) | 8 (Eye) | B (Excision) | Vitreous biopsy if tissue sampling is performed for diagnostic confirmation β Body Part: Vitreous (Right = 5) |
PCS Documentation Requirements
ICD-10-PCS code building requires precision in approach (e.g., Percutaneous = intravitreal), substance (corticosteroid, anti-infective, other therapeutic substance), and device (no device vs. drainage device). If documentation does not specify the substance class administered, a CDI query is appropriate to support complete and accurate PCS code assignment.
π Coding Scenarios and Examples
Scenario 1 β Idiopathic Disseminated Chorioretinitis, Right Eye (Inpatient Admission)
Clinical Vignette: A 38-year-old female is admitted with a 4-day history of progressive blurred vision and new floaters in the right eye. Dilated fundus exam demonstrates multiple white, fluffy lesions scattered throughout the right fundus with moderate vitritis. Fluorescein angiography shows hyperfluorescent lesions with late staining. Extensive laboratory workup β including toxoplasma IgG/IgM, RPR/FTA-ABS, QuantiFERON-TB Gold, HIV antigen/antibody, and CMV PCR β returns negative. Impression documented: idiopathic disseminated chorioretinitis, right eye. Admitted for IV corticosteroid therapy.
Principal Diagnosis:
- H30.101 β Unspecified disseminated chorioretinal inflammation, right eye
Additional Diagnoses: Document all comorbidities meeting UHDDS criteria.
MS-DRG Assignment:
- DRG 126 β Other Disorders of the Eye without CC/MCC (assuming no significant comorbidities)
- DRG 125 β with CC; DRG 124 β with MCC
Scenario 2 β Toxoplasmic Retinochoroiditis, Disseminated Pattern, Right Eye (Inpatient)
Clinical Vignette: A 49-year-old immunocompetent male presents with decreasing vision, right eye. Fundus exam reveals multiple satellite lesions adjacent to an old chorioretinal scar in the right eye, consistent with reactivation of ocular toxoplasmosis with a disseminated multifocal pattern. Toxoplasma IgG positive, IgM negative, consistent with reactivated infection. Admitted for initiation of systemic anti-toxoplasma therapy (trimethoprim-sulfamethoxazole plus prednisone taper).
Principal Diagnosis:
- B58.01 β Toxoplasma chorioretinitis (underlying etiology drives the admission; sequence first)
Additional Diagnosis:
- H30.101 β Unspecified disseminated chorioretinal inflammation, right eye (specifies the disseminated pattern not captured by the combination code alone)
Sequencing Note
B58.01 is a combination code that already incorporates the chorioretinal manifestation of toxoplasmosis. Evaluate whether adding H30.101 provides clinically meaningful additional information about the pattern (disseminated vs. focal) that is not captured by the combination code. When pattern specificity adds clinical detail relevant to resource use or severity, assign both. When it is redundant, B58.01 alone may suffice β apply clinical judgment and payer guidelines.
Scenario 3 β CMV Retinitis in HIV Patient with Disseminated Chorioretinal Involvement, Right Eye (Inpatient)
Clinical Vignette: A 44-year-old male with known HIV (CD4 count 22 cells/ΞΌL, AIDS stage) is admitted for sudden-onset visual loss, right eye. Retinal examination reveals diffuse, confluent areas of retinal whitening with hemorrhage in a βbrushfireβ pattern throughout the right fundus. CMV PCR from aqueous is positive. Impression: CMV retinitis with disseminated chorioretinal involvement, right eye. IV ganciclovir initiated; ophthalmology and infectious disease co-managing.
Principal Diagnosis:
- B20 β Human immunodeficiency virus (HIV) disease (per ICD-10-CM Official Guidelines Section I.C.1.a.2: B20 sequences as principal when a patient with HIV is admitted for an HIV-related condition)
Additional Diagnoses:
- B25.8 β Other cytomegaloviral diseases (CMV retinitis)
- H30.101 β Unspecified disseminated chorioretinal inflammation, right eye (disseminated pattern specificity)
MS-DRG Assignment:
- This encounter groups to MDC 25 (HIV/AIDS), NOT MDC 02, because B20 is principal. DRG assignment follows the HIV/AIDS GROUPER logic.
MDC Override β HIV Principal Diagnosis
Scenario 4 β Outpatient Ophthalmology Follow-Up (Physician / Outpatient Setting)
Clinical Vignette: Established patient returns for 6-week follow-up of known disseminated chorioretinal inflammation, right eye, currently managed with oral prednisone. Comprehensive ophthalmological examination performed. OCT posterior segment and fundus photography obtained to assess lesion activity and retinal thickness.
CPT Procedure Codes:
- 92014 β Ophthalmological services, comprehensive examination, established patient
- 92250 β Fundus photography with interpretation and report
- 92134 β Scanning computerized ophthalmic diagnostic imaging, posterior segment (OCT)
ICD-10-CM Diagnosis Code:
- H30.101 β Unspecified disseminated chorioretinal inflammation, right eye
β οΈ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| β | Do not default to H30.109 (unspecified eye) when laterality is documented anywhere in the record β operative notes, clinic notes, imaging reports, or the discharge summary all count |
| β | Do not confuse focal (H30.0x) with disseminated (H30.1x). Focal = single discrete lesion. Disseminated = multifocal or widespread. The distinction must be documented by the physician |
| β | Do not code H30.101 simultaneously with H35.021 (exudative retinopathy / Coats disease) β this is an Excludes 1 violation and a payer audit risk |
| β | Do not assume laterality from contextual clues without explicit physician documentation β query if uncertain |
| β | Assign etiology codes when identified β toxoplasmosis, syphilis, TB, CMV. Failure to code the causative condition misrepresents clinical complexity |
| β | Query for anatomic distribution specificity β if the ophthalmologist can characterize lesions as posterior pole, peripheral, or generalized, a more specific H30.11x-H30.13x code is appropriate |
| β | In the inpatient setting, review all documented conditions for CC and MCC capture to distinguish DRG 124, 125, or 126 and ensure accurate reimbursement |
| β | Evaluate HIV status and underlying infectious conditions before assigning a principal diagnosis β systemic infectious etiologies can override MDC 02 assignment entirely |
| β | In Medicare Advantage audits, note that H30.101 carries no HCC weight β but related comorbidities (diabetes, autoimmune conditions, immunosuppression) may carry significant risk adjustment value; code them completely |
π Sources
1. CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2025; Tabular List of Diseases and Injuries β H30 Chorioretinal Inflammation category and subcategory notation.
2. Yanoff M, Duker JS. Ophthalmology, 5th ed. Elsevier; 2019. Chorioretinal inflammation and posterior uveitis chapters.
3. CMS. 2024 Medicare Advantage Risk Adjustment β CMS-HCC Model v28 ICD-10-CM Mappings. Baltimore, MD: Centers for Medicare & Medicaid Services.
4. CMS. IPPS Final Rule FY2025 β MS-DRG Definitions Manual v42. Medicare Severity Diagnosis-Related Groups, MDC 02 logic tables.
5. CMS. ICD-10-PCS Reference Manual FY2025; PCS Tables β Section 0 (Medical & Surgical), Body System 8 (Eye); Section 3 (Administration).
6. AMA. CPT Professional Edition 2025. Ophthalmology subsection (92002-92499) and Medicine/Surgery guidelines.
7. CMS. NCCI Policy Manual for Medicare Services, v31.0; Ophthalmology chapter and general correct coding principles.